Miljen Martić

1.5k total citations
12 papers, 186 citations indexed

About

Miljen Martić is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Miljen Martić has authored 12 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Miljen Martić's work include Liver Disease Diagnosis and Treatment (4 papers), Herpesvirus Infections and Treatments (2 papers) and Synthesis and biological activity (2 papers). Miljen Martić is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Herpesvirus Infections and Treatments (2 papers) and Synthesis and biological activity (2 papers). Miljen Martić collaborates with scholars based in Switzerland, United States and Croatia. Miljen Martić's co-authors include Simon M. Ametamey, Keith Graham, Michael Honer, Sandra Borkowski, Linjing Mu, Ananth Srinivasan, Lutz Lehmann, Timo Stellfeld, Ludger M. Dinkelborg and P. August Schubiger and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Hepatology and European Journal of Medicinal Chemistry.

In The Last Decade

Miljen Martić

11 papers receiving 184 citations

Peers

Countries citing papers authored by Miljen Martić

Since Specialization

Citations

This map shows the geographic impact of Miljen Martić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miljen Martić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miljen Martić more than expected).

Fields of papers citing papers by Miljen Martić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miljen Martić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miljen Martić. The network helps show where Miljen Martić may publish in the future.

Co-authorship network of co-authors of Miljen Martić

This figure shows the co-authorship network connecting the top 25 collaborators of Miljen Martić. A scholar is included among the top collaborators of Miljen Martić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miljen Martić. Miljen Martić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction–Associated Steatohepatitis 2025 ·Alimentary Pharmacology & Therapeutics ·Juan P. Frías, Robert Schmouder, Eric Lawitz, Yiming Zhang, Heng Zhou, Michael K. Badman, Chinweike Ukomadu, H. Weiss, (unknown), Brijesh Yadav, Miljen Martić, Clive Drakeford, Phillip J. Koo, Nikolai V. Naoumov, Linda E. Greenbaum	1
2	Identifying signatures of image phenotypes to track treatment response in liver disease 2025 ·Artificial Intelligence in Medicine ·Matthias Perkonigg, Nina Bastati, Ahmed Ba‐Ssalamah, Peter Mesenbrink, Alexander Goehler, Miljen Martić, (unknown), Michael Trauner, Georg Langs	0
3	Magnetic resonance elastography (MRE) demonstrate the strongest correlation with digital pathology and NASH CRN fibrosis assessments, compared to transient elastography and other assessed non-invasive tests (NITs) 2022 ·Journal of Hepatology ·Miljen Martić, Dean Tai, Nikolai V. Naoumov, Elaine Chng, Clifford A. Brass, Juergen Loeffler, (unknown), (unknown), Shenglin Ma, Andreas W. Sailer, Dominique Brees, Zachary Goodman, Marcos Pedrosa, Quentin M. Anstee	2
4	LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Daniel J. Rader, Eleftheria Maratos–Flier, (unknown), (unknown), (unknown), Yi-Fang Li, (unknown), Miljen Martić, Markus Hinder, Craig T. Basson, David Yowe, John L. Diener, Allison B. Goldfine, (unknown), Archna Bajaj, Maricer P. Escalón, (unknown), (unknown), Martin Kankam, Michael J. Koren, (unknown), Jessica R. Wilson	49
5	Nidufexor, a non-bile acid FXR agonist, decreases ALT and hepatic fat fraction in patients with NASH after 12 weeks dosing 2020 ·Journal of Hepatology ·Richard Aspinall, Mustafa M. Shennak, (unknown), Dean Quinn, (unknown), Valentina Molteni, Chinweike Ukomadu, Bindi Sohal, Yiming Zhang, Miljen Martić, Alexandre Avraméas, (unknown), (unknown), Rachel L. Soon, Michael K. Badman	8
6	SAT-357-Tropifexor, a farnesoid X receptor agonist for the treatment of non-alcoholic steatohepatitis: Interim results based on baseline body mass index from first two parts of Phase 2b study FLIGHT-FXR 2019 ·Journal of Hepatology ·Arun J. Sanyal, Patricia López, Eric Lawitz, Won Kim, Jee‐Fu Huang, Pietro Andreoné, George Boon‐Bee Goh, Yi‐Cheng Chen, Vlad Ratziu, Yoon Jun Kim, Marno Ryan, Martin Weltman, Andreas Geier, Juergen Loeffler, F Schaefer, Sujata Vaidyanathan, Miljen Martić, Clifford A. Brass	22
7	¹⁸F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors 2011 ·Journal of Nuclear Medicine ·Michael Honer, Linjing Mu, Timo Stellfeld, Keith Graham, Miljen Martić, Cindy R. Fischer, Lutz Lehmann, P. August Schubiger, Simon M. Ametamey, Ludger M. Dinkelborg, Ananth Srinivasan, Sandra Borkowski	55
8	Synthesis, Crystal Structure, and in Vitro Biological Evaluation of C-6 Pyrimidine Derivatives: New Lead Structures for Monitoring Gene Expression in Vivo 2011 ·Nucleosides Nucleotides & Nucleic Acids ·Miljen Martić, L. Pernot, (unknown), Remo Perozzo, Tatjana Gazivoda Kraljević, (unknown), Silvana Raić‐Malić, Léonardo Scapozza, Simon M. Ametamey	9
9	Synthesis and evaluation of a C-6 alkylated pyrimidine derivative for the in vivo imaging of HSV1-TK gene expression 2011 ·Nuclear Medicine and Biology ·(unknown), Miljen Martić, Tatjana Gazivoda Kraljević, (unknown), Tobias L. Roß, Charlene Ranadheera, Adrienne Müller, (unknown), Stefanie D. Krämer, Silvana Raić‐Malić, Simon M. Ametamey	5
10	In Vitro and in Vivo Characterization of Novel ¹⁸F-Labeled Bombesin Analogues for Targeting GRPR-Positive Tumors 2010 ·Bioconjugate Chemistry ·Linjing Mu, Michael Honer, (unknown), Miljen Martić, P. August Schubiger, Simon M. Ametamey, Timo Stellfeld, Keith Graham, Sandra Borkowski, Lutz Lehmann, Ludger M. Dinkelborg, Ananth Srinivasan	28
11	Synthesis, biological activity and molecular modeling studies of novel COX-1 inhibitors 2004 ·European Journal of Medicinal Chemistry ·Miljen Martić, (unknown), (unknown), (unknown), Sanja Koštrun	6
12	Synthesis, Biological Activity and Molecular Modeling Studies of Novel COX‐1 Inhibitors 2004 ·ChemInform ·Miljen Martić, (unknown), (unknown), (unknown), Sanja Koštrun	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact